<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336311">
  <stage>Registered</stage>
  <submitdate>5/12/2010</submitdate>
  <approvaldate>24/10/2011</approvaldate>
  <actrnumber>ACTRN12611001101976</actrnumber>
  <trial_identification>
    <studytitle>Use of The Laryngeal Mask Airway Unique for Adenotonsillectomy</studytitle>
    <scientifictitle>We will to compare the safety between the disposable unique laryngeal mask airway and the tracheal tube for adenotonsillectomy in paediatric patients</scientifictitle>
    <utrn>U1111-1118-4244</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Laryngospasm during the surgery and at the recovery room</healthcondition>
    <healthcondition>Hypoxia before, during and after anaesthesia</healthcondition>
    <healthcondition>Bronchospasm during the surgey and at the recovery room</healthcondition>
    <healthcondition>Gastric contents regurgitation</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The patients will be randomised by sealed envelopes. After premedication with oral midazolam the children will be monitored with EKG, peripheral oxygen saturation, non invasive blood pressure. The anesthetic induction will be inhalatory with sevoflurane plus O2/N2O (50%) in a Jackson Rees device and hydratation with Ringer's solution. After propofol 1.5mg.kg and fentanyl 2.0mcg.kg, according the randomization we will to use the disposable Unique LMA, choosing the size and insertion techinique according the manufactor's indication or a laryngoscopie with Miller's blade and a paedicatric cuffed tracheal tube, proper to child size . The surgeon will to use the Mc Ivory device to open the mouth and at the end of the surgical procedure, we will perform a tracheoscopy with a apropriated size flexibe fiberscope, to look for blood or secretions. We will analyse the oxygen level at the follow times: 1-after remove the facial mask, 2-after the insertion of the respiratory device (LMA or tracheal tube), 3-after the patient positioning (neck hyperextension), 4- after remove the respiratory device, 5-at admitssion in the recovery room. We will register  the occurence of: respiratory adverse events like hypoxia (definied as oxygen saturation bellow 92%), laryngospasm, bronchospasm, cough, and stridor. After 24 hours, by a phone call, we will ask about nausea, vomits and sore throat. The duration of this study will be about 6 hours at the hospital.</interventions>
    <comparator>The tracheal intubation is the gold standard method for anaesthesia in adenotonsillectomies. Our aim is to compare the safety and the surgical conditions, (visual field, because the LMA cuff can obstruct the surgeons view) of the LMA and the tracheal tube</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Laringospasm: Clinical aspects of respiratory movements (thorax and abdominal), respiratory sounds, stethoscopic sounds, pulse oximetry value</outcome>
      <timepoint>1-Induction of anaesthesia
2-After insertion of the respiratory device
3-Positioning the patient for the surgery
4-After take off the respiratory device
5-At the recovery room</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Bronchospasm: respiratory sounds at stethoscopic, capnography curve aspect, pulse oximetry value</outcome>
      <timepoint>1-Indution of anaesthesia
2 After introdution of the respiratory device (LMA or tracheal tube)
3- At oppening the mouth
4- After removal LMA or TT
5- Recovery room</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Cough and stridor: observational aspect of respiratory sounds, oximetry pulse level, respiratory movements (paradoxal movements)</outcome>
      <timepoint>After removal the respiratory device and at recovery room admition</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Difficulties on surgical field: if the LMA can obstruct the vision of the surgeon, by asking him</outcome>
      <timepoint>During tonsils removal</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Candidates for adenotonsillectomies, aged 1-12.</inclusivecriteria>
    <inclusiveminage>1</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>12</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Airway active infecction, infection at the tonsils, gastric-oesophageal reflux, signals or history of difficult airway management, coagulation abnormalities.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Simple randomisation by using a SigmaStart for Windows (Microsoft Corporation - USA)</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Safety - repiratory conditions, looking for falls in oxygen levels, and respiratory events like bronchospasm.
Efficacy - surgical field, the visual conditons for the surgeon</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/12/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>160</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Santa catarina</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Unimed litoral</primarysponsorname>
    <primarysponsoraddress>Av. Marcos Konder, 1233
Itajai, Santa Catarina
CEP: 88301303</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Hospital do Coracao de Balneario Camboriu</fundingname>
      <fundingaddress>Rua Arthur Maxdoose, 180
Balneario Camboriu
Santa Catarina
ZIP 8833000</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>Institutie for Anaesthesia Progress (IPA)</sponsorname>
      <sponsoraddress>Av. Marcos Konder, 1111
Itajai - Santa Catarina - Brazil
CEP 88301303</sponsoraddress>
      <sponsorcountry>Brazil</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Our aim is to compare the disposable LMA and the tracheal tube for adenotonsillectomies. Concerns in respiratory side effects and surgical conditions will be annalise.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CEP-CONEP  Univali</ethicname>
      <ethicaddress>Rua uruguai, 450
Itajai
Santa Catarina
Brazil
ZIP 88300-000</ethicaddress>
      <ethicapprovaldate>29/10/2010</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>15/07/2010</ethicsubmitdate>
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dante Ranieri Junior</name>
      <address>XV Novembro,222 ap 10
Itajai - SC - Brazil
ZIP 88301420</address>
      <phone>Tel: +55-47-33463766</phone>
      <fax>+55-47-33463766</fax>
      <email>sanit@brturbo.com.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dante Ranieri Junior</name>
      <address>XV Novembro, 222 apartment 10 (street)
ZIP 88301420
Itajai
Santa Catarina</address>
      <phone>+55-47-33492176</phone>
      <fax>+55-47-33492176</fax>
      <email>deranieri@terra.com.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>